RNA
Atrium Therapeutics, Inc.
8.30$
-1.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 224.3% | 219.7% | 248.4% | 2,225.9% | 627.0% | 554.0% | 6.9% | 15.0% | 22.0% | 25.5% | 22.3% | |
| – | – | – | -2,125.9% | 100.0% | 100.0% | 100.0% | 100.0% | 78.0% | 100.0% | 100.0% | |
| 176.6% | 183.3% | 194.3% | 2,225.9% | 627.0% | 554.0% | 1,084.9% | 1,630.6% | 1,997.6% | 2,786.0% | 288.7% | |
| – | – | – | 644.1% | 220.4% | 198.3% | 280.9% | 409.1% | 566.8% | 791.4% | 223.8% | |
| – | – | – | 2,869.9% | 847.4% | 752.4% | 1,365.8% | 2,039.6% | 2,542.4% | 3,577.4% | 512.6% | |
| – | – | – | -2,769.9% | -747.4% | -652.4% | -1,265.8% | -1,939.6% | -2,464.4% | -3,477.4% | -412.6% | |
| 0.0% | 0.0% | 0.0% | 189.4% | 318.5% | 3.1% | 6.9% | 61.7% | – | – | – | |
| – | – | – | -2,959.4% | -1,066.6% | -653.5% | -1,265.4% | -1,886.3% | -2,219.9% | -2,957.7% | -412.6% | |
| – | – | – | 189.4% | 318.5% | -5.5% | -6.9% | -53.3% | 20.2% | – | -0.8% | |
| – | – | – | -3,148.8% | -1,066.6% | -648.0% | -1,258.5% | -1,833.0% | -2,219.9% | -2,957.7% | -411.9% | |
| – | – | – | -2,668.9% | -733.0% | -646.9% | -1,259.0% | -1,924.6% | -2,442.4% | -3,452.0% | -410.9% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.